Earnings number will be important, but I'm more interested in them talking about how things are going with Adcetris sales, acceptance of product, and forward-looking guidance as well as any light they can shed on potential new applications for the drug and any positive news for any other drugs in their pipeline. Sitting tight for earnings. Good luck to all longs.
This time, let's all hope that Earnings will do all the talking, and not the shorts!! 2 more hours...I tried to get some options to hedge but there is no liquidity there...premiums are all out of wack!
Sorry for the wait, doing my taxes. It's hard to see all the money that the govt. takes. Oh well.
I don't put much credence in Seeking Alpha articles, as I see you don't either. The article was full of facts but its the interpretation of those facts that I believe are BS. I'm not losing any sleep over that article. The science is solid here and can only grow into something bigger and better.
Here's some facts- % of Shares Held by Institutional & Mutual Fund Owners:112% % of Float Held by Institutional & Mutual Fund Owners:114%. Do you think they know something?
Sidebar- Glad to see your into EXAS, When I have time I'm checking out the others you mentioned. GLTY.
A little side bar, as a lab tech this company (EXAS) should interest you. Simple stool test, detects all 4 stages of colon cancers, 100% sensitivity, nobody else in its space. Just waiting on FDA approval.
I believe SGEN will do fine with earnings, just don't know if share price will respond in kind.